Trials / Conditions / Diffuse Midline Glioma (DMG)
Diffuse Midline Glioma (DMG)
3 registered clinical trials studyying Diffuse Midline Glioma (DMG) — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | A Phase I Study of FZ-AD005 in Patients With High-Grade Glioma (HGG) NCT07455045 | Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. | Phase 1 |
| Enrolling By Invitation | Intrathecal Azacitidine and Nivolumab in Patients With Recurrent High-grade Glioma NCT06896110 | Andrew P. Groves | Phase 1 |
| Recruiting | ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS NCT04732065 | Sabine Mueller, MD, PhD | Phase 1 |